Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care?

the Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Association

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care?'. Together they form a unique fingerprint.

Medicine & Life Sciences